Connection

Michael Hallek to Pyrazoles

This is a "connection" page, showing publications Michael Hallek has written about Pyrazoles.
Connection Strength

1.220
  1. Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia. Clin Lymphoma Myeloma Leuk. 2019 11; 19(11):715-722.e6.
    View in: PubMed
    Score: 0.367
  2. The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia. Future Oncol. 2015; 11(1):51-9.
    View in: PubMed
    Score: 0.268
  3. New roles for B cell receptor associated kinases: when the B cell is not the target. Leukemia. 2019 03; 33(3):576-587.
    View in: PubMed
    Score: 0.089
  4. CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia. Leukemia. 2019 05; 33(5):1161-1172.
    View in: PubMed
    Score: 0.088
  5. Chronic lymphocytic leukaemia. Lancet. 2018 04 14; 391(10129):1524-1537.
    View in: PubMed
    Score: 0.083
  6. NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int J Cancer. 2018 01 15; 142(2):322-333.
    View in: PubMed
    Score: 0.081
  7. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2017 Sep; 92(9):946-965.
    View in: PubMed
    Score: 0.081
  8. Targeting of B-cell receptor signalling in B-cell malignancies. J Intern Med. 2017 11; 282(5):415-428.
    View in: PubMed
    Score: 0.078
  9. COVID-19 among fit patients with CLL treated with venetoclax-based combinations. Leukemia. 2020 08; 34(8):2225-2229.
    View in: PubMed
    Score: 0.024
  10. Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors. Biomed Res Int. 2018; 2018:1023490.
    View in: PubMed
    Score: 0.021
  11. Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood. 2017 09 21; 130(12):1477-1480.
    View in: PubMed
    Score: 0.020
  12. Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue. Br J Haematol. 2017 09; 178(6):949-953.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.